CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $65.35M, above the global median of $16.24M
- FinancialsAltman Z-Score 8.29: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
7.69%Above 5Y avg (4.58%)
Annual Rate
CNY 2.00Paid annual
Payout Ratio
126.9%High
Payback Period
11.8 yr
Last Ex-Dividend
Jul 1, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.08BCNY902.15M · vs all stocks (USD)
Trailing P/E
13.10xRevenue (TTM)
2.02BCNY300.21M · vs all stocks (USD)
Profit Margin
22.89%Beta
0.0610xvs all stocks
52-Week Change
-23.60%vs all stocks
Market Capitalization
6.08BCNY902.15M · vs all stocks (USD)
Enterprise Value
4.37BCNY647.66M · vs all stocks (USD)
Trailing P/E
13.10xForward P/E
11.13xPrice to Sales (TTM)
2.99xPrice to Book (MRQ)
2.04xEnterprise to Revenue
2.16xEnterprise to EBITDA
4.04xGross Margin
81.87%Profit Margin
22.89%Operating Margin
56.26%Return on Assets (TTM)
12.51%Return on Equity (TTM)
20.24%Revenue (TTM)
2.02BCNY300.21M · vs all stocks (USD)
Revenue per Share (TTM)
8.61CNYUpdated Aug 18, 2026Quarterly Revenue Growth
-33.10%Gross Profit (TTM)
1.69BCNY251.24M · vs all stocks (USD)
EBITDA (TTM)
1.32BCNY195.94M · vs all stocks (USD)
Net Income (TTM)
463.31MCNY68.71M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-39.40%Operating Cash Flow (TTM)
1.24BCNY183.36M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
440.67MCNY65.35M · vs all stocks (USD)
Trailing Annual Dividend Rate
2.00CNYUpdated Aug 18, 2026Trailing Annual Dividend Yield
7.69%vs all stocks
5-Year Average Dividend Yield
4.58%vs all stocks
Payout Ratio
126.90%Minority Interest (Equity)
1.49BCNYFY2025 · Dec 31, 2025Revenue
2.23BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
331.79MCNYFY2025 · Dec 31, 2025Gross Profit
1.90BCNYFY2025 · Dec 31, 2025Operating Income
1.19BCNY176.98M · vs all stocks (USD)
Pre-tax Income
1.21BCNYFY2025 · Dec 31, 2025Income Tax Expense
178.45MCNYFY2025 · Dec 31, 2025Net Income
1.03BCNYFY2025 · Dec 31, 2025EBIT
1.19BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.30BCNYFY2025 · Dec 31, 2025Research & Development
91.10MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
337.62MCNYFY2025 · Dec 31, 2025Other Operating Expenses
46.01MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
24.06MCNYFY2025 · Dec 31, 2025EPS (Basic)
2.28CNYFY2025 · Dec 31, 2025EPS (Diluted)
2.28CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
234.69MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
234.69MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
1.03BCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-493.47MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
1.08BCNYFY2025 · Dec 31, 2025Free Cash Flow
1.05BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
2.00BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
1.03BCNYFY2025 · Dec 31, 2025Other Non-cash Items
3.80MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
64.61MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-20.34MCNYFY2025 · Dec 31, 2025Capital Expenditures
-23.48MCNYFY2025 · Dec 31, 2025Purchase of Investments
-3.34BCNYFY2025 · Dec 31, 2025Sale of Investments
3.12BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-242.45MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-585.83MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-585.83MCNYFY2025 · Dec 31, 2025Shares Outstanding
234.33MSharesUpdated Aug 18, 2026Float Shares
159.96MSharesUpdated Aug 18, 2026% Held by Insiders
35.26%vs all stocks
% Held by Institutions
9.32%vs all stocks
Total Cash (MRQ)
3.26BCNY483.83M · vs all stocks (USD)
Total Cash per Share (MRQ)
13.92CNYUpdated Aug 18, 2026Total Debt (MRQ)
0.00CNYvs all stocks (USD)
Total Debt to Equity (MRQ)
0.00xCurrent Ratio (MRQ)
12.06xBook Value per Share (MRQ)
12.68CNYUpdated Aug 18, 2026Total Assets
5.00BCNY741.23M · vs all stocks (USD)
Total Current Assets
3.63BCNYFY2025 · Dec 31, 2025Total Liabilities
647.45MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.37BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
96.12MCNYFY2025 · Dec 31, 2025Total Current Liabilities
551.33MCNYFY2025 · Dec 31, 2025Cash
2.00BCNYFY2025 · Dec 31, 2025Cash Equivalents
18.23MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.01BCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.25BCNYFY2025 · Dec 31, 2025Accounts Receivable
67.34MCNYFY2025 · Dec 31, 2025Inventory
78.41MCNYFY2025 · Dec 31, 2025Accounts Payable
36.87MCNYFY2025 · Dec 31, 2025Other Current Liabilities
16.66MCNYFY2025 · Dec 31, 2025Common Stock (Book)
234.33MCNYFY2025 · Dec 31, 2025Retained Earnings
2.44BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.35BCNY645.22M · vs all stocks (USD)
52-Week Low
23.93CNYUpdated Aug 18, 202652-Week High
36.16CNYUpdated Aug 18, 202652-Week Change
-23.60%vs all stocks
Beta
0.0610xvs all stocks
50-Day MA
26.11CNYUpdated Aug 18, 2026200-Day MA
30.37CNYUpdated Aug 18, 2026Avg 10-Day Volume
2.47MSharesUpdated Aug 18, 2026Avg 30-Day Volume
2.63MSharesUpdated Aug 18, 2026Diluted EPS (TTM)
1.97CNYUpdated Aug 18, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 1.27Dividend per Share: 2.00Earnings per Share: 1.97
Financial Health
Altman Z-Score 8.29: safe zoneNotable
Altman Z-Score: 8.29
High structural barrier to entryNotable
Barrier to Entry: 0.92
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $65.35M, above the global median of $16.24MNotable
Levered free cash flow (USD): 65,351,021.69Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Hubei Biocause Heilen Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
LB Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
China Isotope & Radiation Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Hangzhou Biotest Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Wuhan Keqian Biology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
DNA Link Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Wanbangde Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Cloudbreak Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Wuhan Huakang Century Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
InMode Ltd.
Tier 1ProductionApproval-Gated PipelineRule